e-ISSN 2598-3849       print ISSN 2527-8878

Vol 8, No 1 (2023)

Home > Vol 8, No 1 (2023) > Hasibuan

Korelasi Faktor Risiko Usia Pasien dengan Kasus dan Biaya Rawat Inap Penyakit Jantung di Indonesia (Analisis Serial Waktu Program Jaminan Kesehatan Nasional 2015-2021)

Syarif Rahman Hasibuan, Sabarinah Sabarinah, Ede Surya Darmawan

Abstract


Penelitian ini menganalisis hubungan antara usia pasien dengan kasus, dan biaya rawat inap penyakit jantung di Indonesia. Desain penelitian ini adalah kuantitatif potong lintang menggunakan data sampel terbuka dari BPJS Kesehatan. Unit sampel pada penelitian ini adalah kasus rawat inap peserta program Jaminan Kesehatan Nasional 2015-2021 dengan jumlah sampel 43.921 yang dibobotkan menjadi 3.901.373 kasus rawat inap. Hasil penelitikan ini menunjukkan terjadi peningkatan kasus dan total biaya rawat inap penyakit jantung pada 2015-2019, namun turun saat pandemi Covid-19. Rata-rata biaya rawat inap penyakit jantung per kasus adalah 7,5 juta rupiah per tahun. Rata-rata biaya tertinggi per kasus adalah 185,47 juta rupiah per tahun; biaya terendah 1,5 juta rupiah per tahun; dan rata-rata total biaya 3,99 Triliun rupiah per tahun. Akumulasi biaya tahun 2015-2021 adalah 27,94 Triliun rupiah. Korelasi spearman menunjukkan bahwa terdapat hubungan antara usia dengan kasus, rata-rata dan total biaya rawat inap dengan kekuatan korelasi dan pola yang bervariasi. Korelasi dengan pola negatif hanya terjadi pada usia dengan rata-rata biaya rawat inap yang artinya semakin tinggi usia, maka rata-rata biaya rawat inap semakin rendah.

Keywords


Penyakit Jantung; Biaya Rawat Inap; Jaminan Kesehatan Nasional

References


Badan Pusat Statistik. (2023). Angka Harapan Hidup (AHH) Menurut Provinsi dan Jenis Kelamin (Tahun), 2020-2022. https://www.bps.go.id/indicator/40/501/1/angka-harapan-hidup-ahh-menurut-provinsi-dan-jenis-kelamin.html

Bakker, J. (2020). Lives at risk due to 50% drop in heart attack A&E attendances. British Heart Foundation. https://www.bhf.org.uk/what-we-do/news-from-the-bhf/news-archive/2020/april/drop-in-heart-attack-patients-amidst-coronavirus-break

Bhatt, A. S., Moscone, A., McElrath, E. E., Varshney, A. S., Claggett, B. L., Bhatt, D. L., Januzzi, J. L., Butler, J., Adler, D. S., & Solomon, S. D. (2020). Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. Journal of the American College of Cardiology, 76(3), 280–288.

BPJS Kesehatan. (2022). Laporan Pengelolaan Program dan Laporan Keuangan 2020-2021.

BPJS Kesehatan. (2023). Laporan Pengelolaan Program Tahun 2022 dan Laporan Keuangan Tahun 2022 (Auditan).

Delima, D., & Siswoyo, H. (2009). Prevalensi dan faktor determinan penyakit jantung di Indonesia.

Dhingra, R., & Vasan, R. S. (2012). Age as a risk factor. Medical Clinics, 96(1), 87–91.

He, Q., Dou, Z., Su, Z., Shen, H., Mok, T.-N., Zhang, C. J. P., Huang, J., Ming, W.-K., & Li, S. (2023). Inpatient costs of congenital heart surgery in China: results from the National Centre for Cardiovascular Diseases. The Lancet Regional Health–Western Pacific, 31.

Hu, S. S., Kong, L. Z., Gao, R. L., Zhu, M. L., Wen, W., Wang, Y. J., Wu, Z. S., Chen, W. W., & Liu, M. B. (2012). Outline of the report on cardiovascular disease in China, 2010. Biomedical and Environmental Sciences, 25(3), 251–256.

Kania, D. (2023). Law, Public Health, NCDs. WHO Indonesia - NPO Policy and Legislation.

Kementerian Kesehatan RI. (2019). Indonesia Masuki Periode Aging Population.

sehatnegeriku.kemkes.go.id/baca/umum/20190704/4530734/indonesia-masuki-periode-aging-population/

Kementerian Kesehatan RI. (2022). Penyakit Jantung Penyebab Utama Kematian, Kemenkes Perkuat Layanan Primer. https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20220929/0541166/penyakit-jantung-penyebab-utama-kematian-kemenkes-perkuat-layanan-primer/

Kiss, P., Carcel, C., Hockham, C., & Peters, S. A. E. (2021). The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review. European Heart Journal-Quality of Care and Clinical Outcomes, 7(1), 18–27.

Marijon, E., Karam, N., Jost, D., Perrot, D., Frattini, B., Derkenne, C., Sharifzadehgan, A., Waldmann, V., Beganton, F., & Narayanan, K. (2020). Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study. The Lancet Public Health, 5(8), e437–e443.

Mensah, G. A., Roth, G. A., & Fuster, V. (2019). The global burden of cardiovascular diseases and risk factors: 2020 and beyond. In Journal of the American College of Cardiology (Vol. 74, Issue 20, pp. 2529–2532). American College of Cardiology Foundation Washington, DC.

Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., & Abdollahpour, I. (2020). Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1223–1249.

Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., & Abdalla, S. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2197–2223.

National Center for Cardiovascular - China. (2018). Report on Cardiovascular Disease in China 2018.

National Institutes of Health. (2023). Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC). report.nih.gov/funding/categorical-spending

Pastori, D., Pignatelli, P., Menichelli, D., Violi, F., & Lip, G. Y. H. (2019). Integrated care management of patients with atrial fibrillation and risk of cardiovascular events: the ABC (Atrial fibrillation Better Care) pathway in the ATHERO-AF study cohort. Mayo Clinic Proceedings, 94(7), 1261–1267.

Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., & Lewington, S. (2013). The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PloS One, 8(7), e65174.

Sniderman, A. D., & Furberg, C. D. (2008). Age as a modifiable risk factor for cardiovascular disease. The Lancet, 371(9623), 1547–1549.

Wang, S., Petzold, M., Cao, J., Zhang, Y., & Wang, W. (2015). Direct medical costs of hospitalizations for cardiovascular diseases in Shanghai, China: trends and projections. Medicine, 94(20).

Willems, R. (2023). How health economic studies can help improve care of patients with congenital heart disease. The Lancet Regional Health–Western Pacific, 31.

Willyono, A., Presley, B., Kamallan, C., Primayani, D., Setiawan, E., Herawati, F., Budiarto, G., Susanto, H., Haryo, P., & Gondosudijanto, I. (2018). Penyakit kardiovaskular: Seri pengobatan rasional. Graha Ilmu.

Wosik, J., Clowse, M. E. B., Overton, R., Adagarla, B., Economou-Zavlanos, N., Cavalier, J., Henao, R., Piccini, J. P., Thomas, L., & Pencina, M. J. (2021). Impact of the COVID-19 pandemic on patterns of outpatient cardiovascular care. American Heart Journal, 231, 1–5


Full Text: PDF

DOI: 10.7454/eki.v8i1.6829

Refbacks

  • There are currently no refbacks.
Creative Commons License

Jurnal Ekonomi Kesehatan Indonesia by http://journal.fkm.ui.ac.id is licensed under a Creative Commons Attribution License.